FrancophonIA/ELRC3.0 huggingface dataset:
English: The majority of events related to the injection site were mild to moderate and less than 0.5 % of patients exposed to galcanezumab during the phase 3 studies discontinued the treatment due to an injection site reaction.
Croatian: Većina događaja povezanih s mjestom injiciranja bila je blage do umjerene težine te je manje od 0,5%
English: Emgality is a solution for injection in a clear glass single-dose syringe.
Croatian: Kako Emgality izgleda i sadržaj pakiranja Emgality je otopina za injekciju u jednodoznoj prozirnoj staklenoj štrcaljki.
English: Compared with placebo-treated patients, patients treated with galcanezumab 120 mg or 240 mg had significantly greater mean decreases from baseline in the number of monthly MHDs at at the first month and at all subsequent months up to month 3 (see Figure 2).
Croatian: 120 mg ili 240 mg opažena je značajno veća srednja vrijednost smanjenja početnog broja dana s migrenskom glavoboljom mjesečno u prvom i svakom sljedećem mjesecu do 3. mjeseca (vidjeti Sliku 2).
English: Dispose of the syringe
Croatian: Odložite štrcaljku
English: Emgality 120 mg solution for injection in pre-filled syringe galcanezumab
Croatian: Emgality 120 mg otopina za injekciju u napunjenoj štrcaljki galkanezumab
English: Compared with placebo-treated patients, patients treated with galcanezumab 120 mg or 240 mg had significantly greater mean decreases from baseline in the number of monthly MHDs at month 1 and at all subsequent months up to month 6 (see Figure 1).
Croatian: 120 mg ili 240 mg opažena je značajno veća srednja vrijednost smanjenja početnog broja dana s migrenskom glavoboljom mjesečno u prvom i svakom sljedećem mjesecu do 6. mjeseca (vidjeti Sliku 1).
English: Parts of the Emgality Syringe
Croatian: Dijelovi štrcaljke s lijekom Emgality
English: Patient-reported Outcome Measures MSQ Role FunctionRestrictive Domainb N Baseline Mean Change Treatment Difference
Croatian: Mjere ishoda koje su prijavili bolesnici MSQ rezultat za funkcionalna ograničenjab
English: Top
Croatian: Gornji dio
English: In patients failing two or more prophylactic treatments, the treatment difference was4.48 days (p < 0.001) between 120 mg and placebo and -1.86 days (p < 0.01) between 240 mg and placebo.
Croatian: bolesnika koji nisu uspješno odgovorili na dva ili više profilaktičkih liječenja, razlika između galkanezumaba 120 mg i placeba iznosila je -4,48 dana (p < 0,001), dok je razlika između galkanezumaba 240 mg i placeba iznosila -1,86 dana (p < 0,01).
English: Parts of the Emgality pen
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Emgality
English: In patients failing two or more prophylactic treatments, the treatment difference was -2.64 days (p < 0.001) between 120 mg and placebo and -3.04 days (p < 0.001) between 240 mg and placebo.
Croatian: U bolesnika koji nisu uspješno odgovorili na dva ili više profilaktičkih liječenja, razlika između galkanezumaba 120 mg i placeba iznosila je -2,64 dana (p < 0,001), dok je razlika između galkanezumaba 240 mg i placeba iznosila -3,04 dana (p < 0,001).
English: Emgality 120 mg solution for injection in pre-filled syringe
Croatian: Emgality 120 mg otopina za injekciju u napunjenoj štrcaljki
English: The pre-filled syringe is for total use only.
Croatian: Napunjena brizgalica namijenjena je samo za primjenu cijele doze.
English: Inspect the syringe and the medicine Make sure you have the right medicine.
Croatian: Prijavljivanjem nuspojava možete pridonijeti u procjeni sigurnosti ovog lijeka.
English: In this patients, the treatment difference observed between galcanezumab 120 mg and placebo and between galcanezumab 240 mg and placebo for the reduction of MHDs in these patients was respectively2.53 days (p < 0.001) and -2.26 days (p < 0.001).
Croatian: U tih je bolesnika razlika između liječenja s obzirom na smanjenje broja dana s migrenskom glavoboljom iznosila -2,53 dana (p < 0,001) za galkanezumab 120 mg u odnosu na placebo te -2,26 dana (p < 0,001) za galkanezumab 240 mg u odnosu na placebo.
English: Each pre-filled syringe contains 120 mg of galcanezumab in 1 mL.
Croatian: Jedna napunjena štrcaljka sadrži 120 mg galkanezumaba u 1 ml otopine.
English: Very common side effects (may affect more than 1 in 10 people): - Injection site pain - Injection site reactions (e.g. red skin, itching, bruising, swelling)
Croatian: - reakcije na mjestu injiciranja (npr. crvenilo kože, svrbež, stvaranje modrica, oticanje) Česte nuspojave (mogu se javiti u do 1 na 10 osoba):
English: Renal elimination of IgG monoclonal antibody is low.
Croatian: IgG monoklonska protutijela u maloj se mjeri eliminiraju kroz bubrege.
English: EU/1/18/1330/001 (1 pre-filled pen) EU/1/18/1330/002 (3 pre-filled pens) EU/1/18/1330/005 (2 pre-filled pens)
Croatian: EU/1/18/1330/005 (2 napunjene brizgalice)
English: No pharmacokinetic drug interactions are expected based on the characteristics of galcanezumab.
Croatian: S obzirom na značajke galkanezumaba ne očekuju se farmakokinetičke interakcije s drugim lijekovima.
English: How to store Emgality 6.
Croatian: Moguće nuspojave 5. Kako čuvati Emgality
English: Tell your doctor or get emergency medical help straight away if you notice any of those signs.
Croatian: Ako primijetite bilo koji od navedenih znakova, odmah se obratite liječniku ili potražite hitnu medicinsku pomoć.
English: ≥ 50 % MHD Responders Percentage, % P-value
Croatian: Bolesnici sa 100%-tnim odgovorom Postotak, %
English: Renal or hepatic impairment
Croatian: - otežano disanje ili gutanje
English: No effects on fertility parameters such as oestrous cycle, sperm analysis, or mating and reproductive performance were observed in rats that were administered galcanezumab (exposures approximately 4 to 20 times the human exposure at 240 mg).
Croatian: U štakora kojima je primijenjen galkanezumab (izloženost približno 4 do 20 puta veća od one u ljudi nakon primjene doze od 240 mg) nisu opaženi učinci na parametre plodnosti, kao što su estrusni ciklus i analiza sperme, kao ni učinci na parenje i reprodukciju.
English: Tel: + 43-(0) 1 711 780
Croatian: Eli Lilly Ges.m.b.H. Tel: + 43-(0) 1 711 780
English: Package leaflet: Information for the patient Emgality 120 mg solution for injection in pre-filled syringe galcanezumab This medicine is subject to additional monitoring.
Croatian: Uputa o lijeku: Informacije za bolesnika Emgality 120 mg otopina za injekciju u napunjenoj štrcaljki galkanezumab
English: Common side effects (may affect up to 1 in 10 people): - Vertigo (a feeling of dizziness or “spinning”) - Constipation - Itching - Rash
Croatian: - vrtoglavica (osjećaj omaglice ili „vrtnje“)
English: Each pre-filled pen contains 120 mg of galcanezumab in 1 mL.
Croatian: Jedna napunjena brizgalica sadrži 120 mg galkanezumaba u 1 ml otopine.
English: Over 2500 patients were exposed to galcanezumab in clinical studies in migraine prophylaxis.
Croatian: U kliničkim ispitivanjima galkanezumaba za profilaksu migrene lijeku je bilo izloženo više od
English: Emgality 120 mg solution for injection in pre-filled pen
Croatian: Emgality 120 mg otopina za injekciju u napunjenoj brizgalici
English: 1 mL of solution in a type I clear glass single-dose syringe.
Croatian: 6.5 Vrsta i sadržaj spremnika 1 ml otopine u jednodoznoj prozirnoj staklenoj štrcaljki (staklo tipa I).
English: Additionally, in month 1, patients treated with galcanezumab (loading dose of 240 mg) demonstrated significantly fewer weekly MHDs compared with placebo-treated patients, at week 1 and each subsequent week.
Croatian: imali značajno manje dana s migrenskom glavoboljom tjedno u usporedbi s bolesnicima koji su primali placebo, i to u prvom i svakom sljedećem tjednu.
English: When you dispose of the syringe and the sharps disposal container:
Croatian: Pri odlaganju brizgalice i spremnika za odlaganje oštrih predmeta: • Pun spremnik za oštre predmete ne smije se reciklirati.
English: Pack sizes of 1, 2 or 3 pre-filled pens.
Croatian: Pakiranja od 1, 2 ili
English: Needle Cap
Croatian: Lilly France
English: Based on a population PK analysis, the apparent clearance of galcanezumab was approximately 0.008 L/hour and the half life of galcanezumab was 27 days.
Croatian: Na temelju populacijske farmakokinetičke analize, prividni klirens galkanezumaba iznosio je približno
English: Use in children under 18 years is not recommended.
Croatian: Ne preporučuje se primjena u djece mlađe od 18 godina.
English: This leaflet was last revised in {MM/YYYY}.
Croatian: Ova uputa je zadnji puta revidirana u {MM/GGGG}
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Croatian: Za sve informacije o ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje u promet lijeka:
English: Prior to distribution of the prescriber guide in each Member State, the MAH must agree the content and format of the educational material, together with a communication plan, with the national competent authority.
Croatian: Prije distribucije vodiča za propisivanje lijeka u svakoj zemlji članici, nositelj odobrenja mora dogovoriti sadržaj i oblik edukacijskog materijala, zajedno s komunikacijskim planom, s nacionalnim nadležnim tijelom.
English: Talk to your doctor before you start to take this medicine: - if you retain water (fluid retention) or have heart failure problems and in particular if you are over 75 years old.
Croatian: Obratite se svom liječniku prije nego uzmete ovaj lijek: - ako zadržavate vodu (nakupljanje tekućine) ili imate tegobe sa zatajivanjem srca, osobito ako ste stariji od 75 godina.
English: (<1/10,000); not known (cannot be estimated from the available data).
Croatian: vrlo rijetko (<1/10 000); nepoznato (ne može se procijeniti iz dostupnih podataka).
English: Reykjavíkurvegi 76-78 220 Hafnarfjörður Iceland
Croatian: Reykjavíkurvegi 76-78 220 Hafnarfjörður Island
English: What Glidipion is and what it is used for
Croatian: Što je Glidipion i za što se koristi
English: If you have the impression that the effect of Glidipion is too weak, talk to your doctor.
Croatian: Ako imate dojam da je učinak lijeka Glidipion preslab, razgovarajte o tome sa svojim liječnikom.
English: Contents of the pack and other information What Glidipion contains
Croatian: Sadržaj pakiranja i druge informacije Što Glidipion sadrži
English: Your doctor will check whether Glidipion is working 3 to 6 months after you start taking it.
Croatian: Liječnik će provjeriti djelovanje lijeka Glidipion 3 do 6 mjeseci nakon što ga počnete uzimati.
English: Glidipion helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.
Croatian: Glidipion pridonosi kontroli razine šećera u krvi kad imate šećernu bolest tipa 2, tako što pomaže Vašem tijelu da bolje iskoristi inzulin koji proizvodi.
English: Pioglitazone and all active metabolites are extensively bound to plasma protein (> 99%).
Croatian: Pioglitazon i svi djelatni metaboliti opsežno se vežu za proteine plazme (>99%).
English: Take Glidipion daily as prescribed.
Croatian: Uzimajte Glidipion svaki dan, onako kako je propisano.
English: Not known (frequency cannot be estimated from the available data) - increase in liver enzymes - allergic reactions
Croatian: nepoznato (učestalost se ne može procijeniti iz dostupnih podataka) - povišenje vrijednosti jetrenih enzima - alergijske reakcije
English: Other medicines and Glidipion
Croatian: Drugi lijekovi i Glidipion
English: Frequencies are defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare
Croatian: Učestalost je navedena kao: vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000);
English: • Patient selection criteria including that Pioglitazone should not be used as first line therapy and emphasising the need for regular review of treatment benefit.
Croatian: • Kriterije za odabir bolesnika uključujući to da se pioglitazon ne smije primjenjivati kao prva linija terapije i naglašavajući potrebu za redovitim provjerama koristi od liječenja.
English: If you have a serious allergic reaction, including hives and swelling of the face, lips, tongue, or throat that may cause difficulty in breathing or swallowing stop taking this medicine and talk to your doctor as soon as possible.
Croatian: Ako imate ozbiljnu alergijsku reakciju, uključujući koprivnjaču i oticanje lica, usana, jezika ili grla to može uzrokovati teškoće s disanjem ili gutanjem, prestanite s uzimanjem lijeka i obratite se svom liječniku što je moguće prije.
English: - if you are hypersensitive (allergic) to pioglitazone or any of the other ingredients of Glidipion
Croatian: - ako ste preosjetljivi (alergični) na pioglitazon ili neki drugi sastojak lijeka Glidipion
English: The Prescriber Guide should highlight the following:
Croatian: Vodič za propisivače lijeka treba istaknuti sljedeće:
English: If you take Glidipion with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia).
Croatian: Ako uzimate Glidipion s drugim lijekovima za šećernu bolest, veća je vjerojatnost da Vam šećer u krvi padne ispod normalne razine (hipoglikemija).
English: If you stop using Glidipion, your blood sugar may go up.
Croatian: Ako prestanete uzimati Glidipion, šećer u krvi Vam se može povisiti.
English: Glidipion has no or negligible effect on the ability to drive and use machines.
Croatian: Glidipion ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada na strojevima.
English: Almost all subjects (95%) were receiving cardiovascular medicinal products (beta blockers, ACE inhibitors, angiotensin II antagonists, calcium channel blockers, nitrates, diuretics, aspirin, statins, fibrates).
Croatian: Gotovo su svi bolesnici (95%) primali kardiovaskularne lijekove (beta blokatore, ACE inhibitore, antagoniste angiotenzina II, blokatore kalcijevih kanala, nitrate, diuretike, aspirin, statine, fibrate).
English: What Glidipion looks like and contents of the pack
Croatian: Kako Glidipion izgleda i sadržaj pakiranja
English: Before you start taking Glidipion you will have a blood sample taken to check your liver function.
Croatian: Prije nego što počnete uzimati Glidipion uzet će Vam uzorak krvi da bi se provjerilo kako radi
English: What Glidipion is and what it is used for What you need to know before you take Glidipion How to take Glidipion
Croatian: Što je Glidipion i za što se koristi Što morate znati prije nego počnete uzimati Glidipion Kako uzimati Glidipion
English: Glidipion can be taken with or without food.
Croatian: Glidipion se može uzimati s hranom ili bez nje.
English: These findings were observed across species at plasma concentrations ≤ 4 times the clinical exposure.
Croatian: Ovi su nalazi bili primijećeni u svih vrsta pri koncentracijama u plazmi koje su bile ≤4 puta veće od kliničke izloženosti.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove http://www.ema.europa.eu/.
English: • The physician educational pack should contain: The Summary of Product Characteristics, package leaflet, and a Prescriber Guide.
Croatian: • Edukacijski paket za liječnike treba sadržavati: Sažetak opisa svojstava lijeka, Uputu o lijeku i Vodič za propisivače lijeka.
English: The MAH shall provide an educational pack targeting all physicians who are expected to prescribe/use Pioglitazone.
Croatian: Nositelj odobrenja osigurat će edukacijski paket namijenjen svim liječnicima koji očekuju da će propisivati/primjenjivati pioglitazon.
English: Immune System Disorders
Croatian: Poremećaji imunološkog sustava
English: 14 tablets 28 tablets 30 tablets 50 tablets 56 tablets 84 tablets 90 tablets 98 tablets 100 tablets
Croatian: 14 tableta 28 tableta 30 tableta 50 tableta 56 tableta 84 tablete 90 tableta 98 tableta 100 tableta
English: If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking Glidipion.
Croatian: Ako Vam je liječnik rekao da ne podnosite neke šećere, obratite se liječniku prije nego što uzmete Glidipion.
English: Very common (may affect more than 1 in 10 people) - decreased blood sugar (hypoglycaemia)
Croatian: vrlo često (mogu se javiti u više od 1 na 10 ljudi) - snižen šećer u krvi (hipoglikemija)
English: Glidipion contains pioglitazone.
Croatian: Glidipion sadrži pioglitazon.
English: Glidipion should be used every day to work properly.
Croatian: Da bi Glidipion ispravno djelovao, treba ga uzimati svaki dan.
English: If you are following a diabetic diet, you should continue with this while you are taking Glidipion.
Croatian: Ako se pridržavate dijabetičke dijete, trebate nastaviti s dijetom dok uzimate Glidipion.
English: Postmarketing, bone fractures have been reported in both male and female patients (see section 4.4).
Croatian: Nakon stavljanja lijeka u promet, prijavljeni su prijelomi kostiju i kod muških i kod ženskih bolesnika (vidjeti dio 4.4).
English: In light of age-related risks (especially bladder cancer, fractures and heart failure), the balance of benefits and risks should be considered carefully both before and during treatment in the elderly.
Croatian: U svjetlu rizika povezanih sa životnom dobi (osobito karcinoma mokraćnog mjehura, prijeloma i zatajenja srca), potrebno je pažljivo razmotriti ravnotežu između koristi i rizika kako prije, tako i tijekom liječenja starijih bolesnika.
English: Broken bones have been reported commonly (up to 1 in 10 people) in female patients taking pioglitazone and have also been reported in male patients (frequency cannot be estimated from the available data) taking pioglitazone.
Croatian: Prijelomi kostiju su često prijavljivani (u do 1 na 10 ljudi) u žena koje su uzimale pioglitazon, a također su prijavljivani i u muškaraca (učestalost se ne može procijeniti iz dostupnih podataka) koji su uzimali pioglitazon.
English: If you take more Glidipion than you should
Croatian: Ako uzmete više Glidipion tableta nego što ste trebali
English: • Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Croatian: • Oprez kod primjene u starijih s obzirom na rizike povezane s dobi (osobito karcinom mokraćnog mjehura, prijelome kostiju i zatajenje srca).
English: At two years, glycaemic control (defined as HbA1c < 8.0%) was sustained in 69% of patients treated with pioglitazone, compared with 50% of patients on gliclazide.
Croatian: Nakon dvije godine, kontrola glikemije (definirana kao HbA1c <8,0%) bila je održana u 69% bolesnika liječenih pioglitazonom u odnosu na 50% bolesnika koji su uzimali gliklazid.
English: Pharmacotherapeutic group: Drugs used in diabetes, blood glucose lowering drugs, excl. insulins; ATC code: A10BG03.
Croatian: Farmakoterapijska skupina: Pripravci za liječenje šećerne bolesti; Oralni lijekovi za snižavanje glukoze u krvi, osim inzulina; ATK oznaka: A10BG03.
English: These effects were independent of pioglitazone's effects on glycaemia and were statistically significant different to glibenclamide.
Croatian: Ti su učinci bili neovisni o učincima pioglitazona na glikemiju i statistički značajno različiti u odnosu na glibenklamid.
English: When Glidipion is taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines.
Croatian: Kad se Glidipion uzima zajedno s drugim lijekovima za liječenje šećerne bolesti (kao što su inzulin, klorpropamid, glibenklamid, gliklazid, tolbutamid) liječnik će Vam reći trebate li te lijekove uzimati u manjim dozama.
English: Glidipion may be used on its own in patients who are unable to take metformin, and where treatment with diet and exercise has failed to control blood sugar or may be added to other therapies (such as metformin, sulphonylurea or insulin) which have failed to provide sufficient control of blood sugar.
Croatian: Glidipion se može primjenjivati sam u bolesnika koji ne mogu uzimati metformin, a kod kojih se liječenjem dijetom i tjelovježbom nije uspjela postići kontrola šećera u krvi ili se može dodati drugim lijekovima (kao što su metformin, sulfonilureja ili inzulin) koji nisu uspjeli osigurati dostatnu kontrolu šećera u krvi.
English: Signs and symptoms include blood in your urine, pain when urinating or a sudden need to urinate.
Croatian: Znakovi i simptomi uključuju krv u mokraći, bol pri mokrenju i iznenadnu potrebu za mokrenjem.
English: Cases of bladder cancer were reported more frequently in a meta-analysis of controlled clinical trials with pioglitazone (19 cases from 12506 patients, 0.15%) than in control groups (7 cases from 10212 patients, 0.07%) HR=2.64 (95% CI 1.11-6.31, P=0.029).
Croatian: U meta-analizi kontroliranih kliničkih ispitivanja češće su zabilježeni slučajevi karcinoma mokraćnog mjehura u skupinama koje su primale pioglitazon (19 slučajeva na 12 506 bolesnika, 0,15%) nego u kontrolnim skupinama (7 slučajeva na 10 212 bolesnika, 0,07%) HR=2,64 (95% CI 1,11-6,31, P=0,029).
English: Within each frequency grouping, adverse reactions are presented in order of decreasing incidence and seriousness.
Croatian: U svakoj skupini učestalosti nuspojave su prikazane slijedom prema sve manjoj incidenciji i ozbiljnosti.
English: Pioglitazone will not affect your ability to drive or use machines but take care if you experience abnormal vision.
Croatian: Pioglitazon neće utjecati na Vašu sposobnost upravljanja vozilima i rada na strojevima, ali budite oprezni ako osjetite promjene vida.
English: It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus, when metformin is not suitable or has failed to work adequately.
Croatian: To je antidijabetički lijek koji se primjenjuje za liječenje šećerne bolesti tipa 2 (neovisne o inzulinu), kad metformin nije pogodan ili nije imao odgovarajuće djelovanje.
English: • This educational pack is aimed at strengthening awareness of important identified risks of bladder cancer and heart failure and the overall recommendations intended to optimise the benefit-risk margin at the patient level.
Croatian: • Svrha ovog edukacijskog paketa jest povisiti svijest o važnosti utvrđenih rizika od karcinoma mokraćnog mjehura i zatajenja srca te sveukupne preporuke namijenjene optimizaciji raspona koristi u odnosu na rizik na razini bolesnika.
English: For the 14, 28, 56, 84 and 98 tablets pack sizes, you can check the day on which you last took a tablet of Glidipion by referring to the calendar printed on the blister.
Croatian: Za pakiranja koja sadrže 14, 28, 56, 84 i 98 tableta, možete provjeriti dan kad ste uzeli zadnju Glidipion tabletu na kalendaru tiskanom na blisteru.
English: Since insulin and pioglitazone are both associated with fluid retention, concomitant administration may increase the risk of oedema.
Croatian: Budući da su i inzulin i pioglitazon povezani sa zadržavanjem tekućine, njihova istodobna primjena može povećati rizik od edema.
English: OTHER (FOR CALENDARISED PACKS SIZES OF 14, 28, 56, 84 AND 98 TABLETS ONLY)
Croatian: DRUGO (SAMO ZA PAKIRANJA S KALENDAROM OD 14, 28, 56, 84 I 98 TABLETA)
English: Environmental Risk Assessment: no environmental impact is anticipated from the clinical use of pioglitazone.
Croatian: Procjena rizika za okoliš: ne očekuje se utjecaj na okoliš tijekom kliničke primjene pioglitazona.
English: No dose adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/min) (see section 5.2).
Croatian: Nije potrebna prilagodba doze u bolesnika s oštećenom funkcijom bubrega (klirens kreatinina > 4 ml/min) (vidjeti dio 5.2).
English: The other side effects that have been experienced by some patients when pioglitazone is taken with other antidiabetic medicines are:
Croatian: Druge nuspojave koje su neki bolesnici osjetili kod uzimanja pioglitazona s drugim antidijabetičkim lijekovima su:
English: Package leaflet: Information for the user
Croatian: Uputa o lijeku: Informacija za bolesnika